Limits and perspective of oral therapy with statins and aspirin for the prevention of symptomatic cholesterol gallstone disease

Author： Cariati Andrea   Piromalli Elisa  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.9, 2012-06, pp. : 1223-1227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Inhibition of Intestinal Cholesterol Absorption on the Prevention of Cholesterol Gallstone Formation

By  

Medicinal Chemistry, Vol. 13, Iss. 5, 2017-07 ,pp. : 421-429

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Reflections in Cholesterol Homeostasis and Gallstone Disease: A Review

By  

Current Medicinal Chemistry, Vol. 21, Iss. 12, 2014-04 ,pp. : 1435-1447

Bentham Science Publishers

Access to resources Recommend Favorite

Should We Encourage Over-The-Counter Statins?: A Population Perspective for Coronary Heart Disease Prevention

By Gemmell Islay  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 4, 2007-01 ,pp. : 299-302

Adis International

Access to resources Recommend Favorite

Farnesoid X receptor agonism – a new approach to the treatment of cholesterol gallstone disease

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 4, 2005-04 ,pp. : 535-538

Informa Healthcare

Access to resources Recommend Favorite

Role of Dual Antiplatelet Therapy in Symptomatic Patients with Established Vascular Disease: Putting the CHARISMA Trial into Therapeutic Perspective

By Boden William   Flather Marcus   Bhatt Deepak  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 3, 2010-06 ,pp. : 207-216

Springer Publishing Company

Access to resources Recommend Favorite